Paul Sundberg
Member of the Board of Directors @Abintus Bio, Inc
Signup · Get unlimited contacts
WORK HISTORY
Member of the Board of Directors @Abintus Bio, Inc
Abintus Bio is a bio-technology company that is pioneering potentially curative, off-the-shelf genetic medicines that engineer cells directly inside the patient’s body, also termed in vivo. These therapies are based on Abintus’ clinically proven Modular Delivery Platform (MDP). The company’s two initial, fit-for-purpose, In Vivo programs are: 1. Highly selective gene expression targeting cell type/state via synthetic biology (e.g, In Vivo CAR-NK/T/Treg, In Vivo TCR-T) with applications across multiple gene delivery systems (e.g, AAV, lenti, adeno, retro) and therapeutic areas including leukemia, solid tumors, autoimmune, infectious, and genetic disease, and 2. Simultaneous engineering of a diverse repertoire of active innate and adaptive immune cells (e.g, In Vivo CAR-X) with applications in diseases such as lymphoma and solid tumors.
EDUCATION
Tulane University Law School
JD, Law
Southern Methodist University
Bachelor of Science (B.S.), Economics & Finance
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.